Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01072409 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System

A NA study, sponsored by Cochlear.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT01072409: Completed NA study, sponsored by Cochlear.

NCT01072409 is a NA study that has completed, run by Cochlear. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01072409, a NA study, has completed, sponsored by Cochlear.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

To evaluate the performance of the Nucleus 5 Cochlear Implant System.

Primary Outcome

CNC Word Test is a validated test of open-set word recognition. The test consists of 10 lists with 50 monosyllabic words in each list. Subject responses are scored for both words and phonemes correct in the correct sequence. Subjects will be tested using a configuration of speech at 0º azimuth in quiet.

Interventions

  • DEVICE Cochlear implantation
  • DEVICE Nucleus 5 Cochlear implant

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2010-03
Est. Completion 2012-11
Phase NA
Cochlear

34 total trials

What the finished NCT01072409 record still lists

NCT01072409 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Cochlear implantation is the first listed.

NCT01072409 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01072409 about?

NCT01072409 is a clinical study titled "Clinical Evaluation of the Nucleus 5 Cochlear Implant (CI) System". To evaluate the performance of the Nucleus 5 Cochlear Implant System.

What is the current status of trial NCT01072409?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2010-03. Estimated completion is 2012-11.

What interventions are being tested in trial NCT01072409?

The interventions under investigation include: Cochlear implantation (DEVICE), Nucleus 5 Cochlear implant (DEVICE).

Who is sponsoring clinical trial NCT01072409?

This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01072409's enrollment target sits among peer trials

49 1379th of 2000 higher than 620 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01072409, the US trial registry maintained by the National Library of Medicine. NCT01072409 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.